2,4-Dichlorobenzyl Alcohol/ Amylmetacresol [Discontinued in SA Market]
Indications
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
- Minor mouth and throat infections
Cautions
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
Contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
Cautions
- Pregnancy
- Breastfeeding
- Children < 6 years
- Fructose intolerance
- Glucose-galactose malabsorption
- Sucrose-isomaltose insufficiency
Adult dosage
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
Forms avail. in SA and covered in this monograph: loz
Symptomatic relief of minor mouth and throat infections
Relief of cough associated with colds and allergies
2,4-Dichlorobenzyl Alcohol/ Amylmetacresol
1.2/0.6 (mg)
- Oral (loz): 1 loz, 2-3hrly; Max: 12 loz/24hrs
Paediatric dosage
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
Paed. forms avail. in SA and covered in this monograph: loz
Symptomatic relief of minor mouth and throat infections
Cough associated with colds and allergies
2,4-Dichlorobenzyl Alcohol/ Amylmetacresol
1.2/0.6 (mg)
- Younger than 12 years: Not established for use
- Older than 12 years: Oral (loz): 1 loz, 2-3hrly; Max: 8 loz/24hrs
Special populations
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
Pregnancy
- Caution
- There are no or limited amount of data from the use of amylmetacresol and 2,4-dichlorobenzyl alcohol. As with all medicines care should be taken when using this combination product in pregnancy
Breastfeeding
- Caution
- It is unknown whether 2,4-dichlorobenzyl alcohol, amylmetacresol or metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
Gastrointestinal Disorders
- Glossodynia
- Oral discomfort
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity
Interactions
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
No known significant interactions
Mechanism of action
Please note that the products associated with this active ingredient monograph have all been discontinued in the South African market (Effective: October 2020).
The information in this monograph has not been updated and remains on the EMGuidance platform for reference purposes only.
2,4-Dichlorobenzyl alcohol and amylmetacresol have antiseptic properties.
Dosage forms
- Lozenge
References
1. https://drive.google.com/drive/folders/1Sd97jCRW7uRhQs0cZatelibZR4oZBkEB (23/07/2010_Reckitt_Strepsils loz) 2. https://www.medicines.org.uk/emc/medicine/23391(07/04/2017_Reckitt Benckiser_Strepsils_loz) 3. NAPOS The Drug Database for Acute Porphyria: Amylmetacresol, Dichlorobenzyl alcohol; Accessed online 28 Jan 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s1.php?l=gbr] 4. South African Institute for Drug-Free Sport; Strepsils; Accessed online 04 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
0 products · cached snapshot- Strepsils
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.